With a five-year EPS forecast of 158.80%, Alphatec Holdings, Inc. (NASDAQ:ATEC) is among the 12 Best Future Stocks to Buy Right Now.
On May 7, Barclays analyst Matt Miksic lowered the firm’s price target on Alphatec Holdings, Inc. to $24 from $27 while maintaining an Overweight rating on the shares. Despite the lower target, Barclays kept a bullish stance on the stock, suggesting continued confidence in Alphatec’s long-term growth prospects despite near-term operational challenges.
The same day, Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Alphatec Holdings, Inc. to $14 from $25 while also maintaining an Overweight rating. The firm noted that first-quarter results came in below expectations, driven by a disappointing EOS quarter and softer-than-expected revenue per case due to unfavorable product mix headwinds, though the continued Overweight rating suggests that analysts still see upside from current levels over time.
Alphatec Holdings, Inc. is a medical technology company focused on designing, developing, and advancing surgical solutions and devices specifically for the treatment of spinal disorders. The company aims to improve outcomes in spine surgery through a combination of innovative implants, enabling technologies, and procedural solutions tailored to surgeons and patients. It is headquartered in Carlsbad, California, and was founded in 1990.
READ NEXT: 7 Best Heavy Equipment Stocks to Buy as Backlogs Hit Records and 9 Best Natural Gas Stocks to Buy for Transitional Power.